Merck Global Health Innovation Fund logo

Merck Global Health Innovation Fund

North America, New Jersey, United States, Whitehouse Station

Description

Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare

Investor Profile

Merck Global Health Innovation Fund has made 97 investments, with 8 in the past 12 months and 47% as lead.

Stage Focus

  • Series B (26%)
  • Series Unknown (25%)
  • Series A (12%)
  • Series C (11%)
  • Series D (10%)
  • Post Ipo Equity (4%)
  • Series E (3%)
  • Private Equity (3%)
  • Seed (2%)
  • Series F (1%)

Country Focus

  • United States (88%)
  • Canada (4%)
  • United Kingdom (3%)
  • Denmark (2%)
  • India (1%)
  • Hungary (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Information Technology
  • Software
  • Health Diagnostics
  • Medical Device
  • Analytics
  • Pharmaceutical
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Merck Global Health Innovation Fund frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 4
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 7
Safeguard Scientifics
North America, Pennsylvania, United States, Radnor
Co-Investments: 6
Zaffre Investments
North America, Massachusetts, United States, Boston
Co-Investments: 4
7wire Ventures
North America, Illinois, United States, Chicago
Co-Investments: 9
Excel Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
McKesson Ventures
North America, California, United States, San Francisco
Co-Investments: 5
Kinnevik
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 4
Threshold
North America, California, United States, Menlo Park
Co-Investments: 7
HLM Venture Partners
North America, Massachusetts, United States, Boston
Co-Investments: 4

Which angels does Merck Global Health Innovation Fund often collaborate with?

PZ
North America, United States
Shared Deals: 1
MA
North America, California, United States, San Francisco
Shared Deals: 1
SD
North America, United States
Shared Deals: 1
Shared Deals: 1
BB
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Merck Global Health Innovation Fund?

Variational AI

Vancouver, British Columbia, Canada

Generative AI for drug discovery

Artificial Intelligence (AI)BiotechnologyGenerative AIMachine Learning
SeedFeb 20, 2025
Amount Raised: $5,500,000
Evaxion Biotech

Copenhagen, Hovedstaden, Denmark

Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.

Biotechnology
Post Ipo EquityJan 30, 2025
Amount Raised: $10,800,000
Ash

New York, New York, United States

At-home health testing solutions tailored to reach your unique population.

Health CareHealth DiagnosticsmHealthWellness
Series UnknownOct 16, 2024
Amount Raised: $10,000,000
Qure AI

Andheri, Maharashtra, India

Qure AI is a healthcare technology company that provides automated interpretation of radiology exams and ultrasounds scans.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedical Device
Series DJun 25, 2024
CargoSense

Reston, Virginia, United States

CargoSense provides data driven logistics to the healthcare industry utilizing a disruptive business model.

AnalyticsBig DataCloud ComputingHealth CareInternet of ThingsLogisticsSaaS
Series AJun 12, 2024
Amount Raised: $8,000,000
Atropos Health

Palo Alto, California, United States

Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.

Clinical TrialsHealth CareInformation TechnologyMedical
Series BMay 23, 2024
Amount Raised: $33,000,000
N-Power Medicine

Redwood City, California, United States

N-Power Medicine specializes in drug development and clinical research.

BiotechnologyClinical TrialsPharmaceutical
Series BMay 21, 2024
Transcarent

Denver, Colorado, United States

Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.

Health CarePersonal HealthSoftware
Series DMay 2, 2024
Amount Raised: $126,000,000
Baseimmune

London, England, United Kingdom

Baseimmune is a biotech startup founded to create the next generation of vaccines.

BiotechnologyHealth CareLife Science
Series AFeb 26, 2024
Amount Raised: $11,415,554
Evaxion Biotech

Copenhagen, Hovedstaden, Denmark

Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.

Biotechnology
Post Ipo EquityFeb 1, 2024
Amount Raised: $15,000,000